Antimalarial drugs in the treatment of rheumatological diseases

Guidelines for the use of systemic drugs in the treatment of skin diseases

Systemic drugs are used in the treatment of several skin diseases. In order to obtain best therapeutic results and prevent side effects, the patients should be carefully screened before and thoroughly evaluated during treatment. In this article guidelines for selection and follow up of patients receiving systemic drugs for their skin diseases are presented. These drugs include azathioprine, ant...

Dyslipidaemia in Rheumatological Autoimmune Diseases

Autoimmunity forms the basis of many rheumatological diseases, and may contribute not only to the classical clinical manifestations but also to the complications. Many of the autoimmune rheumatological diseases, including rheumatoid arthritis and systemic lupus erythematosus are associated with an excess cardiovascular morbidity and mortality. Much of this excess cardiovascular risk can be attr...

Rheumatological manifestations of haematological diseases.

In a review published in 1983, an attempt was made to highlight the rheumatological aspects of diseases generally regarded as haematological in origin.' Since then, a variety of reports have served to strengthen the links between these two areas of medicine. In this review, we consider these more recent reports and focus on patient presentation, advances in treatment, and knowledge of underlyin...

The History of Antimalarial Drugs

The use of antimalarial drugs.

or translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The designation employed and the presentation of the material in this publication, including maps and tables do not imply the expression of any opinion whatsoever on the part of the secretariat of the World Health Organization concerning the legal status of any country, territory, city or a...